retatrutide cardiovascular effects and Risk: Evaluating Heart Rate and Outcomes Retatrutide, Tirzepatide and Survodutide in

How to spot red flags in weight loss products There is an overwhelming amount of information about weight loss available online, making it hard to know who and what to trust

Standard-dose protocols may produce stronger appetite suppression, but they can also create a higher likelihood of noticeable side effects during escalation

Rhett explained

Readout is also expected in Q2-Q3 2026

Pivovarova O, Hohn A, Grune T, Pfeiffer AF, Rudovich N

Evidence-Based Management of MASLD and MASH in Patients with Obesity Date: Friday, April 25, 2025 Time: 1:50 PM 2:35 PM East Coast USA Time Location: Potomac AB Description: Up to 90% of individuals with obesity are affected by Metabolic Associated Steatotic Liver Disease (MASLD), and a significant number are at risk of progressing to Metabolic Associated Steatohepatitis (MASH) and liver fibrosis